tevogen.com (TVGN) - Soliqlar to‘langandan keyingi foyda

TVGN (tevogen.com) - kompaniyaning tovar belgisi

Tevogen Bio Holdings (TVGN) aktivlar qiymatining ushbu grafigi foyda dinamikasini namoyish etadi, u hozirda -0.02 darajasida turibdi. Kompaniyaning muvaffaqiyati aksiyalar opsionlari va akademik mustaqillik tizimi orqali T-hujayralar terapiyasi ekspertlarini jalb qilishga asoslangan. Ishlab chiqarish zavodlarining yo'qligi sababli biznes minimal ekologik izni saqlaydi, shu bilan birga laboratoriya xavfsizligi va ma'muriy idoralarda energiyadan samarali foydalanish ustuvor vazifalar bo'lib qolmoqda.

Sof daromad: Tevogen Bio Inc. (TVGN) 21.02.2024 - 31.10.2026 uchun

Tevogen Bio (TVGN) moliyaviy va bozor koʻrsatkichlari kesimi

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi Tevogen Bio Inc.|TVGN - Konsensus maqsadli narx
- bozor kapitallashuvi ko'rsatkichlari:
Bozor qiymati Tevogen Bio Inc.|TVGN - Korxona qiymati
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
Bitta aksiya hisobiga sof aktivlar qiymati Tevogen Bio|TVGN - Kompaniyaning sof aktivlari|Bozor qiymatining balans qiymatiga nisbati tevogen.com|TVGN - Kompaniyaning jami aktivlari
- qarz yuki va likvidlik ko'rsatkichlari:
Qarzning kapitalga nisbati Tevogen Bio Holdings|TVGN - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzdorlikning o'z kapitaliga nisbati Tevogen Bio Holdings Inc.|TVGN - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Tevogen Bio Inc.|TVGN - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Tevogen Bio|Oraliq qoplash koeffitsiyenti tevogen.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
TVGN - Sof foyda
Fundamental baholash:TVGN Tevogen Bio Inc.
Tevogen Bio brend mahsuloti

Tevogen Bio Holdings (TVGN) foydasi operatsion samaradorlikning fundamental ko'rsatkichi bo'lib xizmat qiladi va sof moliyaviy natija prizmasi orqali biznesning barqarorligini baholash imkonini beradi. Ushbu metrika emitentning barcha xarajatlarni qoplagandan keyin pul oqimini yaratish qobiliyatini o'lchaydi. Kompaniyaning foyda dinamikasini tahlil qilish orqali investorlar rentabellik qonuniyatlarini va siklik pasayishlar xavfini aniqlaydilar. Tevogen Bio Holdings (TVGN) uchun ushbu ko'rsatkichning barqaror o'sishi hujayra terapiyalarining tijorat qiymatini tasdiqlaydi va murakkab patologiyalarni davolashning innovatsion usullariga bozor ishonchini aks ettiradi.

Asosiy raqobatchilar

Kompaniyaning sof daromadi Biogen Idec (BIIB)|Sof daromad NBIX|RGC (regencellbioscience.com) - Soliqlar to‘langandan keyingi foyda|Sof foyda AXSM|ACAD - Kompaniyaning sof daromadi|Xenon Pharmaceuticals Inc - Sof daromad|Viking Therapeutics Corp - Kompaniyaning sof foydasi|SUPN - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi catalystpharma.com|DNLI: Sof foyda|Yillik sof foyda Harmony Biosciences Inc HRMY|BHVN (Biohaven Pharmaceutical) - Sof foyda|Kompaniyaning sof daromadi Amylyx Corp AMLX|Kompaniyaning sof foydasi Trevi Therapeutics (TRVI)|praxismedicines.com - Kompaniya foydasi|Anavex Life Sciences Corp. - Sof daromad|Yakuniy foyda CBLL|Prothena Biosciences - Sof foyda|ALEC: Kompaniyaning sof foydasi|ANNX: Sof foyda|OMER - Sof moliyaviy natija|Kompaniyaning sof foydasi Neurogene|Kompaniyaning sof daromadi AC Immune S.A. ACIU|Sof daromad VYGR (Voyager Pharma)|NMRA (Neumora Corp) - Yakuniy foyda|Sof foyda SCLX (Scilex Holding Company)|Yakuniy foyda ACOG|CGTX - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Inhibikase Therapeutics Inc|Cassava (SAVA) - Kompaniyaning sof foydasi|ASRT (Assertio) - Kompaniyaning sof foydasi|COYA (Coya Therapeutics Inc) - Sof foyda|Kompaniya foydasi VTGN (VistaGen Therapeutics Inc)|Sof foyda OVID|Sof moliyaviy natija Acumen Pharmaceuticals Inc.|Kompaniyaning sof foydasi CervoMed Inc CRVO|ATHE: Kompaniya foydasi|Clene Nanomedicine - Sof foyda|Yillik sof foyda PepGen Inc. (PEPG)|Jupiter Neurosciences Inc (JUNS) - Kompaniyaning sof foydasi|RLMD - Sof moliyaviy natija|Sof daromad ANVS|GRCE (Grace Tx) - Soliqlar to‘langandan keyingi foyda|Sof daromad AIFF (Firefly Neuroscience, Inc)|Kompaniyaning sof foydasi KLTO (anewmeds.com)|Sof foyda NRSN (NeuroSense Therapeutics Ltd.)|Yillik sof foyda Reviva Pharmaceuticals Holdings Inc.|MTVA - Kompaniyaning sof foydasi|NRXS (NeurAxis Inc) - Kompaniya foydasi|heliusmedical.com (HSDT) - Kompaniyaning sof foydasi|Kompaniya foydasi PASG|NEUP (Neuphoria Therapeutics, Inc.) - Sof foyda|Kompaniyaning sof daromadi Minerva Neurosciences Inc NERV|Sof daromad ATHA (Athira)|Sof foyda Addex (ADXN)|Kompaniyaning sof foydasi Alzamend Neuro ALZN|Yakuniy foyda CYCN|PTIX - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Pasithea Therapeutics|CRGT (cortigent.com) - Sof daromad|ATXI: Soliqlar to‘langandan keyingi foyda|BCLI (Brainstorm Cell) - Sof foyda|Kompaniyaning sof daromadi caratherapeutics.com CARA|Sof daromad CHRO (Chromocell Therapeutics Corp.)|Kompaniyaning sof foydasi ELYM (eliemtx.com)|Kompaniyaning sof foydasi Intra-Cellular Therapies, Inc. ITCI|Longboard (LBPH) - Kompaniyaning sof daromadi|Marinus Pharmaceuticals - Sof foyda|Yillik sof foyda nkgenbiotech.com (NKGN)|NRBO: Sof foyda|Kompaniyaning sof daromadi Sage Therapeutics Inc. (SAGE)|Kompaniyaning sof foydasi Neurotrope|Kompaniya foydasi TRVN (Trevena Inc)|Sof daromad VIGL (Vigil Neuroscience)|WENA (Anew Medical Inc.) - Yakuniy foyda|Sof foyda CERE (Cerevel Therapeutics, Inc.)